Sato, Sunayama, and colleagues have shown that concurrent inhibition of this pathway and PI3K/Akt/mTOR induces differentiation of undifferentiated glioma stem-like cells via activating FoxO3a transcriptional activity [196]. The gene discussed is AKT1; the disease is glioma.